Detalhe da pesquisa
1.
Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.
Haemophilia
; 27(3): e331-e339, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772963
2.
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A.
Haemophilia
; 26(3): 478-486, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32338433
3.
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.
Blood
; 130(19): 2055-2063, 2017 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28912376
4.
Pharmacokinetic equivalence, comparable safety, and immunogenicity of an adalimumab biosimilar product (M923) to Humira in healthy subjects.
Pharmacol Res Perspect
; 6(1)2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29417761
5.
An innovative outcome-based care and procurement model of hemophilia management.
Expert Rev Pharmacoecon Outcomes Res
; 16(3): 337-45, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27074697
6.
Global Post-Authorization Safety Surveillance Study: real-world data on prophylaxis and on-demand treatment using FEIBA (an activated prothrombin complex concentrate).
Blood Coagul Fibrinolysis
; 27(5): 551-6, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26829366
7.
Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability.
Immunotherapy
; 8(10): 1175-86, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27468136
8.
Demonstration of safety of intravenous immunoglobulin in geriatric patients in a long-term, placebo-controlled study of Alzheimer's disease.
Alzheimers Dement (N Y)
; 2(2): 131-139, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29067300
9.
Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants.
Vaccine
; 31(35): 3611-6, 2013 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-23672977